Clinical Trial

Scientific Validity Assessment and Optimization of AI-Generated A3/A4 Type Questions for the Chinese Medical Licensing Examination

Recruiting
View on ClinicalTrials.gov →
Summary
This is a cross-sectional study that primarily employs quantitative analysis, supplemented by qualitative assessment. The research is conducted in two stages: Phase I consists of a model performance comparison experiment, and Phase II involves an item quality evaluation experiment. The entire study adheres to the principles of single-blinding, randomization, and standardization to ensure scientific rigor and reproducibility. The single-blind design is implemented during the "standardized testing" phase, where the system intersperses AI-generated items with those authored by human experts. Participants remain blinded to the source of each item (AI-generated vs. human-authored) throughout the testing and scoring processes, thereby ensuring the objectivity of the evaluation results.
Trial Details
NCT Number NCT07505862
Lead Sponsor Guangdong Provincial People's Hospital
Conditions AI (Artificial Intelligence)
Enrollment 20 participants
Start Date 2025-10-01
Primary Completion 2026-03-30 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-01